By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Arrowhead Research Corporation 

1118 East Green Street

Pasadena  California  91106  U.S.A.
Phone: 626-792-5549 Fax: 626-792-5554


SEARCH JOBS

Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silence disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead’s pipeline includes clinical programs in chronic hepatitis B virus and obesity and partner-based programs in oncology.


Key Statistics


Email: info@arrowres.com
Ownership: Public

Web Site: Arrowhead Research Corporation
Employees:
Symbol: ARWR
 



Industry
Medical Device






Company News
Arrowhead Research Corporation (ARWR) To Report Fiscal 2015 Third Quarter Financial Results 7/29/2015 11:02:07 AM
Arrowhead Research Corporation (ARWR) Receives Regulatory Clearance For ARC-AAT Phase 1 In The United Kingdom And New Zealand 7/8/2015 9:47:20 AM
Arrowhead Research Corporation (ARWR) Initiates Dosing Of ARC-AAT In Patients With Alpha-1 Antitrypsin Deficiency 7/2/2015 9:18:49 AM
Arrowhead Research Corporation (ARWR) Receives Regulatory Clearance To Begin Additional Phase 2b Studies Of Hepatitis B Candidate ARC-520 6/17/2015 11:09:28 AM
Arrowhead Research Corporation (ARWR) Receives Orphan Drug Designation For ARC-AAT 6/10/2015 7:29:37 AM
Arrowhead Research Corporation (ARWR) To Present At Jefferies and Co. 2015 Healthcare Conference 5/27/2015 11:19:28 AM
Arrowhead Research Corporation (ARWR) Reports Fiscal 2015 Second Quarter Financial Results 5/12/2015 11:04:23 AM
Arrowhead Research Corporation (ARWR) Presents Data On Potential RNAi Candidate Targeting Factor 12 Mediated Angioedemic And Thromboembolic Diseases 5/7/2015 11:11:21 AM
Arrowhead Research Corporation (ARWR) Completes Dosing Healthy Volunteers And Initiates Transition To Patients In Phase 1 Study Of ARC-AAT 5/5/2015 10:40:10 AM
Arrowhead Research Corporation (ARWR) Publishes Data On Advances In Subcutaneous siRNA Delivery 4/30/2015 9:59:48 AM
12345678910...
//-->